Sub headings in a bold font and increased point size
Placeholder introduction copy: IPF is a form of lung disease that causes scarring (fibrosis) of the lungs; people living with IPF have a poor prognosis and symptoms that significantly impact their quality of life.
Since 2013, the Registry has collected real-world clinical data on over 5,000 IPF patients from 64 centres across the UK. These findings provide valuable insights into patient demographics, diagnostic trends, and treatment patterns, shaping the future of IPF care.
- Key findings from the Registry published today in the BMJ Open Respiratory Research Journal include:
Patient demographics
IPF is more prevalent in men (77.8%), with an average age of 74 years. Over half (66%) were ex-smokers, and 76% had at least one co-morbidity.
Sub headings in a bold font and increased point size
Placeholder introduction copy: IPF is a form of lung disease that causes scarring (fibrosis) of the lungs; people living with IPF have a poor prognosis and symptoms that significantly impact their quality of life.